Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 483 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
483
Total Funding
$2.3B
Avg Funding
$91.7M
Cities
21

Export 483 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Toronto, Canada
$432K
raised

Arch Biopartners acquires and develops products and technology for sale to pharmaceutical and industrial companies.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boulder, United States
$150.0M
raised

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

La Jolla, United States
$11.0M
raised

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$3.0M
raised

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Wroclaw, Poland
$17.7M
raised

Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lund, Sweden
$967K
raised

Hamlet BioPharma is a pharmaceutical company with strong links to research.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Branford, United States
$31.0M
raised

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Sioux Falls, United States
$85.0M
raised

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$60.0M
raised

Ovid Therapeutic's purpose is to solve intractable medical problems.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
La Jolla, United States
$35.0M
raised

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$589K
raised

Lancaster Resources is a dynamic exploration company dedicated to the emerging energy sector transition opportunity.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$719.0M
raised

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New Haven, United States
$8.0M
raised

BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miami, United States
$30.0M
raised

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$85.0M
raised

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Charlestown, United States
$240.0M
raised

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$7.1M
raised

Defence Therapeutics is a scientific pioneer on a journey to uncover enhanced treatment solutions for future generations.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$1.1M
raised

GenFlow Biosciences is a biotech company that develops gene therapies for slow or reverse aging in humans and animals.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Chicago, United States
$30.0M
raised

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Altrincham, United Kingdom
$200.0M
raised

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Freehold, United States
$9.8M
raised

Avalon GloboCare is a biotech company that develops diagnostics, cellular therapies, along with health tech products.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Henderson, United States
$144.0M
raised

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wayne, United States
$200.0M
raised

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$150.0M
raised

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 151 to 175 of 483 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 483 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

483 Biotechnology Post-IPO Equity Startups (November 2026) — Page 7 | VCBacked